Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Relugolix |
Trade Name | |
Synonyms | TAK-385|Relumina |
Drug Descriptions |
Relugolix (TAK-385) is a gonadotropin-releasing hormone antagonist, which binds to the gonadotropin-releasing hormone receptor, thereby preventing the secretion and release of luteinizing hormone and follicle stimulating hormone and possibly resulting in anti-tumor activity (PMID: 32469183). |
DrugClasses | |
CAS Registry Number | 737789-87-6 |
NCIT ID | C114498 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Abiraterone + Prednisone + Relugolix | Abiraterone Prednisone Relugolix | 0 | 1 |
Abiraterone + Relugolix | Abiraterone Relugolix | 0 | 1 |
Bicalutamide + Pembrolizumab + Relugolix | Bicalutamide Pembrolizumab Relugolix | 0 | 1 |
Darolutamide + Relugolix | Darolutamide Relugolix | 0 | 3 |
Docetaxel + Relugolix | Docetaxel Relugolix | 0 | 1 |
Enzalutamide + Relugolix | Enzalutamide Relugolix | 0 | 3 |
Estradiol + Norethindrone + Relugolix | Estradiol Norethindrone Relugolix | 0 | 0 |
Itraconazole + Relugolix | Itraconazole Relugolix | 0 | 1 |
Relugolix | Relugolix | 0 | 10 |
Relugolix + Ritonavir | Relugolix Ritonavir | 0 | 1 |